JLE

Epileptic Disorders

MENU

Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience Volume 8, numéro 2, June 2006

Anhut et al, 1994 Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994; 35: 795-801.

Arroyo et al, 2004 Arroyo S, Anhut H, Kugler AR, et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004; 45: 20-7.

Barcs et al, 2000 Barcs G, Walker EB, Elger CE, et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 2000; 41: 1597-607.

Ben-Menachem, 1995 Ben-Menachem E. International experience with tiagabine add-on therapy. Epilepsia 1995; 36(suppl. 6): S14-S21.

Ben-Menachem, 1997 Ben-Menachem E. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience. Epilepsia 1997; 38(suppl. 1): S28-S30.

Ben-Menachem et Falter, 2000 Ben-Menachem E, Falter U, for the European Levetiracetam Study Group. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000; 41: 1276-83.

Ben-Menachem et al, 1996 Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996; 37: 539-43.

Beran et al, 1998 Beran RG, Berkovic SF, Dunagan FM, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalized epilepsy. Epilepsia 1998; 39: 1329-33.

Binnie et al, 1987 Binnie CD, Beintema DJ, Debets RM, et al. Seven day administration of lamotrigine in epilepsy: placebo-controlled add-on trial. Epilepsy Res 1987; 1: 202-8.

Binnie et al, 1989 Binnie CD, Debets RM, Engelsman M, et al. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989; 4: 222-9.

Boas et al, 1996 Boas J, Dam M, Friis ML, Kristensen O, Pedersen B, Gallagher J. Controlled trial of lamotrigine (Lamictal®) for treatment-resistant partial seizures. Acta Neurol Scand 1996; 94: 247-52.

Boon et al, 2002 Boon P, Chauvel P, Pohlmann-Eden B, Otoul C, Wroe S. Dose-response effect of levetiracetam 1000 and 2000 mg/d in partial epilepsy. Epilepsy Res 2002; 48: 77-89.

Brodie, 2004 Brodie MJ. Pregabalin as adjunctive therapy for partial seizures. Epilepsia 2004; 45(suppl. 6): 19-27.

Cereghino et al, 2000 Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetam for partial seizures. Results of a double-blind, randomized clinical trial. Neurology 2000; 55: 236-42.

Chadwick, 1991 Chadwick D. Gabapentin. Epilepsy Res 1991; 3(suppl): 183-6.

Chaisewikul et al, 2002 Chaisewikul R, Privitera MD, Hutton JL, Marson AG. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. Cochrane Database Syst Rev 2002; 1; (CD001901).

Crawford et al, 1987 Crawford P, Ghadiali E, Lane R, Blumhardt L, Chadwick D. Gabapentin as an antiepileptic drug in man. J Neurol Neurosurg Psychiatry 1987; 50: 682-6.

Faught, 1997 Faught E. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience. Epilepsia 1997; 38(suppl. 1): S24-S27.

Faught et al, 2001 Faught E, Ayala R, Montouris GG, Leppik IE. Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001; 57: 1774-9.

Faught et al, 1996 Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology 1996; 46: 1684-90.

Fisher et al, 2001 Fisher RS, Sachdeo RC, Pellock J, Penovich PE, Magnus L, Bernstein P. Rapid initiation of gabapentin: a randomized, controlled trial. Neurology 2001; 56: 743-8.

French et al, 2003 French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003; 60: 1631-7.

Guberman et al, 2002 Guberman A, Neto W, Gassmann-Mayer C. EPAJ-119 Study Group. Low-dose topiramate in adults with treatment-resistant partial-onset seizures. Acta Neurol Scand 2002; 106: 183-9.

Jawad et al, 1989 Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989; 30: 356-63.

Kalviainen et al, 1998 Kalviainen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K. A double-blind, placebo-controlled trial of tiagabine given three times daily as add-on therapy for refractory partial seizures. North European Tiagabine Study Group. Epilepsy Res 1998; 30: 31-40.

Korean Topiramate Study Group, 1999 Korean Topiramate Study Group. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Epilepsia 1999; 40: 1767-74.

Kwan et Brodie, 2000 Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-9.

Langfitt et Meador, 2004 Langfitt J, Meador K. Want to improve epilepsy care? Ask the patient. Neurology 2004; 62: 6-7.

Levy et al, 2002 In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic Drugs. Baltimore: 5th ed. Lippincott Williams & Wilkins, 2002.

Loiseau, 1999 Loiseau P. Review of controlled trials of gabitril (tiagabine): a clinician’s viewpoint. Epilepsia 1999; 40(suppl. 9): S14-S19.

Loiseau et al, 1990 Loiseau P, Yuen AW, Duche B, Menager T, Arne-Bes MC. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment resistant partial seizures. Epilepsy Res 1990; 7: 136-45.

Marson et al, 2001 Marson AG, Hutton JL, Leach JP, et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res 2001; 46: 259-70.

Matsuo et al, 1993 Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993; 43: 2284-91.

Messenheimer et al, 1994 Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994; 35: 113-21.

Miller et al, 2003 Miller R, Frame B, Corrigan B, et al. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Clin Pharmacol Ther 2003; 73: 491-505.

Moran et al, 2004 Moran NF, Poole K, Bell G, et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 2004; 13: 425-33.

Peeters et al, 2003 Peeters K, Adriaenssen I, Wapenaar R, Neto W, Pledger G. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Acta Neurol Scand 2003; 108: 9-15.

Pellock, 1994 Pellock JM. The clinical efficacy of lamotrigine as an antiepileptic drug. Neurology 1994; 44(suppl. 8): S29-S35.

Privitera et al, 1996 Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology 1996; 46: 1678-83.

Radtke et Bennett, 2000 Radtke R, Bennett B. Calculating seizure-free rates after long-term AED exposure: impact of methodology using levetiracetam premarketing experience [abstract]. Epilepsia 2000; 41(suppl. 7): 121-2; [Abstract 2.127].

Reife et Pledger, 1997 Reife RA, Pledger GW. Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials. Epilepsia 1997; 38(suppl. 1): S31-S33.

Reife et al, 2000 Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000; 41(suppl. 1): S66-S71.

Richens et al, 1995 Richens A, Chadwick DW, Duncan JS, et al. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial. Epilepsy Res 1995; 21: 37-42.

Sachdeo et al, 1997 Sachdeo RC, Leroy RF, Krauss GL, et al. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group. Arch Neurol 1997; 54: 595-601.

Sander et Bell, 2004 Sander JW, Bell GS. Reducing mortality: an important aim of epilepsy management. J Neurol Neurosurg Psychiatry 2004; 75: 349-51.

Sander et al, 1990 Sander JW, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990; 6: 221-6.

Schapel et al, 1993 Schapel GJ, Beran RG, Vajda FJ, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 1993; 56: 448-53.

Schmidt et Sachdeo, 2000 Schmidt D, Sachdeo R. Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav 2000; 1: 396-405.

Schmidt et al, 1993 Schmidt D, Jacob R, Loiseau P. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993; 15: 67-73.

Sharief et al, 1996 Sharief M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996; 25: 217-24.

Shorvon et al, 2000 Shorvon SD, Löwenthal A, Janz D, Bielen E, Loiseau P, for the European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000; 41: 1179-86.

Sivenius et al, 1991 Sivenius J, Kalviainen R, Ylinen A, Riekkinen P. Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia 1991; 32: 539-42.

Smith et al, 1993 Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 312-22.

Stolarek et al, 1994 Stolarek I, Blacklaw J, Forrest G, Brodie MJ. Vigabatrin and lamotrigine in refractory epilepsy. J Neurol Neurosurg Psychiatry 1994; 57: 921-4.

Tassinari et al, 1996 Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996; 37: 763-8.

US Gabapentin Study Group, 1990 US Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990; 335: 1114-7.

US Gabapentin Study Group No 5, 1993 US Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993; 43: 2292-8.

Uthman et al, 1998 Uthman BM, Rowan AJ, Ahmann PA, et al. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol 1998; 55: 56-62.

Yen et al, 2000 Yen DJ, Yu HY, Guo YC, Chen C, Yiu CH, Su MS. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy. Epilepsia 2000; 41: 1162-6.